News

KineMed received $1.2m reinvestment from The Michael J. Fox Foundation for the further development of kinetic biomarkers predictive of Parkinson’s disease changes ahead of symptoms. The Michael J.

The company provided 96-week data from a pivotal Phase III study in which elvitegravir (150mg or 85mg) dosed once daily was non-inferior to the integrase inhibitor raltegravir (400mg)

Ibandronic Acid is a generic version of Bonviva (Ibandronic Acid) from Roche. The product is indicated for the treatment of osteoporosis in postmenopausal women at increased risk of

The partnership will use IDRI’s synthetic adjuvants in conjunction with Soligenix’s proprietary subunit proteins and thermostability platform (known as ThermoVax). Soligenix president and chief executive officer Christopher Schaber

Duac Gel is indicated for the topical treatment of inflammatory acne vulgaris. Perrigo chairman, president and CEO Joseph Papa said, "We’re pleased to bring this new topical product

Production using the new expanded capacity at its multi-product cGMP active pharmaceutical ingredient (API) manufacturing facility commenced on 1 June 2012. The investment matches the solids handling equipment

With the new agreement, BioDiem gains exclusive license to the technology which, although in development for hepatitis, may also have applicability in a range of other diseases. As

The FDA approved Belviq as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adult patients with an initial body mass index

As part of the merger, Cornerstone will assume the responsibility to market and promote Cardene I.V. (nicardipine hydrochloride) and Retavase (Reteplase). As part of the agreement Cornerstone has